TCM intelligent syndrome-differentiation systems
AI platforms that extract signs from clinical notes and predict TCM syndromes alongside disease diagnosis — in hospital use since a Guang'anmen Hospital platform went live in 2019, with remote service covering six provinces.
1 · What it gives
TCM intelligent syndrome-differentiation systems are AI-assisted platforms that support syndrome differentiation in TCM diagnosis and treatment. They aim to replace or augment parts of the clinician-centred workflow by automating syndrome prediction and supporting reasoning. A system can output a disease-type diagnosis together with a list of probable syndromes. Operational maturity: a hospital system went live in February 2019 and the Guang’anmen Hospital remote service expanded to six provinces.
2 · What it replaces 6
3 · How to implement 4 steps
- 1Digitise captureDigitise data capture of TCM diagnosis and treatment workflows.
- 2Build knowledge basesBuild interoperable knowledge and evidence bases.
- 3Extract and predictExtract signs and symptoms from record text with NLP, then predict syndromes.
- 4Integrate in hospitalsIntegrate into hospital workflows and extend to other facilities.
4 · Who delivers
Matched suppliers (matched automatically)
| AKVA group | Norway | Services / consulting | active |
| Georem International | South Africa | Services / consulting | active |
| EYS Makina | Turkey | Distributor | active |
| Industrias Vepinsa | Mexico | Producer | active |
| Spans Envirotech Pvt. Ltd. | India | Services / consulting | active |
| True Eco Sdn Bhd | Malaysia | Distributor | active |
| FENRI Co., Ltd. | Taiwan | Not classified | active |
| AGROSAVIA | Colombia | Research / RTO | active |
| ATTO | Brazil | Distributor | active |
| Absolute | India | Not classified | active |
| Afrique Phyto Plus - A2P SA | Côte d'Ivoire | Producer | active |
| Agri Phero Solutionz | India | Producer | active |
Leading companies and institutes (from the brief)
Named in the sources: the Beijing University Chongqing Big Data Research Institute and the China Academy of Chinese Medical Sciences, whose Guang’anmen Hospital has had an intelligent TCM diagnosis platform since 2019. Others are matched by the portal under Digital & robotics.
5 · Rules & route to market
state registration ~10-15 working days after expert assessment; new substances need notification
Information, not legal advice — confirm the procedure for your product. (2026-10-06)
United States
The sources reviewed on 2026-10-16 identified no the US regulator or standard specific to this technology. Treat the route as case-by-case and ask for a check.
European Union
The sources reviewed on 2026-10-16 identified no the EU regulator or standard specific to this technology. Treat the route as case-by-case and ask for a check.
China
The sources reviewed name no regulator or standard for these systems; software-as-medical-device and TCM rules should be checked case by case.
6 · Money: tenders & grants
| Grant | First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based … National Institutes of Health · United States | Oct 15, 2027 364 days |
| Grant | NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required) National Institutes of Health · United States | Jul 5, 2029 993 days |
| Grant | Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the … National Institutes of Health · United States | Aug 18, 2027 306 days |
| Grant | Development of Collaborative Research Facilities or Research-Resource Facilities (C06 Clinical Trial Not … National Institutes of Health · United States | Jan 25, 2028 466 days |
| Grant | Development of cell-free protein synthesis platforms for discovery and/or production of biologicals European Commission · EU | Apr 13, 2027 179 days |
7 · Tech stack & innovations
Main risks from the sources: insufficient or low-quality public TCM diagnostic data for training, limited generalisability of models built for specific diseases or syndrome types, and a lack of TCM-appropriate evaluation metrics.
Sources 6
- Cqbdri.pku.edu.cn — cqbdri.pku.edu.cn 2026-10-16
- Gov.cn — www.gov.cn 2026-10-16
- Medinform.jmir.org — medinform.jmir.org 2026-10-16
- Cacms.ac.cn — www.cacms.ac.cn 2026-10-16
- Cq.chinanews.com.cn — www.cq.chinanews.com.cn 2026-10-16
- Engineering.org.cn — www.engineering.org.cn 2026-10-16